Treatment Innovations

Celcuity’s Milestone Moment: FDA Clears Revtorpyk Amidst Market Turbulence

• Treatment Innovations

Celcuity’s Milestone Moment: FDA Clears Revtorpyk Amidst Market Turbulence

Asro July 15, 2026

By Delilah Alvarado Published July 15, 2026 In a watershed moment for Celcuity, the Minneapolis-based biotechnology company...

Read More Read more about Celcuity’s Milestone Moment: FDA Clears Revtorpyk Amidst Market Turbulence

The Invisible Deficit: Why Biopharma’s Knowledge Gap Threatens the Future of Advanced Therapies

• Treatment Innovations

The Invisible Deficit: Why Biopharma’s Knowledge Gap Threatens the Future of Advanced Therapies

Azzam Bilal Chamdy July 15, 2026

In the high-stakes world of biopharmaceutical manufacturing, the most valuable asset is often the one that never...

Read More Read more about The Invisible Deficit: Why Biopharma’s Knowledge Gap Threatens the Future of Advanced Therapies

Beyond Amyloid: Biogen’s ‘Celia’ Trial Signals a Potential Paradigm Shift in Alzheimer’s Treatment

• Treatment Innovations

Beyond Amyloid: Biogen’s ‘Celia’ Trial Signals a Potential Paradigm Shift in Alzheimer’s Treatment

Nana Wu July 15, 2026

The landscape of Alzheimer’s disease research has long been dominated by the “amyloid hypothesis”—the theory that clearing...

Read More Read more about Beyond Amyloid: Biogen’s ‘Celia’ Trial Signals a Potential Paradigm Shift in Alzheimer’s Treatment

From Pens to Pills: The Scientific Paradigm Shift in GLP-1 Drug Development

• Treatment Innovations

From Pens to Pills: The Scientific Paradigm Shift in GLP-1 Drug Development

Nana July 15, 2026

The landscape of metabolic medicine is undergoing a profound transformation. Since the landmark approval of semaglutide (Ozempic)...

Read More Read more about From Pens to Pills: The Scientific Paradigm Shift in GLP-1 Drug Development

FTC Secures Landmark Antitrust Settlement with CVS Caremark: A New Era for Pharmacy Benefit Management

• Treatment Innovations

FTC Secures Landmark Antitrust Settlement with CVS Caremark: A New Era for Pharmacy Benefit Management

Jia Lissa July 15, 2026

In a move poised to reshape the landscape of the American pharmaceutical supply chain, CVS Health’s pharmacy...

Read More Read more about FTC Secures Landmark Antitrust Settlement with CVS Caremark: A New Era for Pharmacy Benefit Management

Insuring the Psychedelic Frontier: Navigating the Liability Landscape of FDA-Approved Psilocybin

• Treatment Innovations

Insuring the Psychedelic Frontier: Navigating the Liability Landscape of FDA-Approved Psilocybin

Pevita Pearce July 14, 2026

Fifty-five years after the Controlled Substances Act of 1970 relegated psilocybin to Schedule I status—placing it alongside...

Read More Read more about Insuring the Psychedelic Frontier: Navigating the Liability Landscape of FDA-Approved Psilocybin

High-Stakes Biotech Feud: Cayman Court Ruling Escalates Battle Between Apple Tree Partners and Rigmora

• Treatment Innovations

High-Stakes Biotech Feud: Cayman Court Ruling Escalates Battle Between Apple Tree Partners and Rigmora

Nana Wu July 14, 2026

By Gwendolyn Wu | July 14, 2026 The high-stakes legal entanglement between venture capital heavyweight Apple Tree...

Read More Read more about High-Stakes Biotech Feud: Cayman Court Ruling Escalates Battle Between Apple Tree Partners and Rigmora

Biopharma Industry Update: Strategic Shifts, Clinical Breakthroughs, and Regulatory Milestones

• Treatment Innovations

Biopharma Industry Update: Strategic Shifts, Clinical Breakthroughs, and Regulatory Milestones

Nana Muazin July 14, 2026

By Ben Fidler | July 13, 2026 The biotechnology and pharmaceutical sectors continue to navigate a period...

Read More Read more about Biopharma Industry Update: Strategic Shifts, Clinical Breakthroughs, and Regulatory Milestones

Beyond the Hunch: Why Rigorous Matching is the New Gold Standard for Real-World Evidence

• Treatment Innovations

Beyond the Hunch: Why Rigorous Matching is the New Gold Standard for Real-World Evidence

Raul Delapena Setiawan July 13, 2026

In the fast-paced world of clinical medicine, the bridge between a physician’s anecdotal observation and a scientifically...

Read More Read more about Beyond the Hunch: Why Rigorous Matching is the New Gold Standard for Real-World Evidence

Q32 Bio’s Redemption: Bempikibart Trial Success Sparks Massive Market Rebound

• Treatment Innovations

Q32 Bio’s Redemption: Bempikibart Trial Success Sparks Massive Market Rebound

Reynand Wu July 13, 2026

By Jonathan Gardner Published July 13, 2026 In a stunning reversal of fortune, shares of Q32 Bio...

Read More Read more about Q32 Bio’s Redemption: Bempikibart Trial Success Sparks Massive Market Rebound